The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global LVAD and RVAD Market Research Report 2024
Synopsis
A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
Global LVAD and RVAD market is projected to reach US$ 4741.1 million in 2029, increasing from US$ 2145 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole LVAD and RVAD market research.
Key manufacturers engaged in the LVAD and RVAD industry include AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, Jarvik Heart, Sun Medical Technology Research and ReliantHeart, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of LVAD and RVAD were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole LVAD and RVAD market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global LVAD and RVAD market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
ReliantHeart
Segment by Type
LVADs
RVADs
Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The LVAD and RVAD report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
Global LVAD and RVAD market is projected to reach US$ 4741.1 million in 2029, increasing from US$ 2145 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole LVAD and RVAD market research.
Key manufacturers engaged in the LVAD and RVAD industry include AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, Jarvik Heart, Sun Medical Technology Research and ReliantHeart, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of LVAD and RVAD were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole LVAD and RVAD market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global LVAD and RVAD market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
ReliantHeart
Segment by Type
LVADs
RVADs
Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The LVAD and RVAD report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 LVAD and RVAD Market Overview
1.1 Product Overview and Scope of LVAD and RVAD
1.2 LVAD and RVAD Segment by Type
1.2.1 Global LVAD and RVAD Market Value Comparison by Type (2023-2029)
1.2.2 LVADs
1.2.3 RVADs
1.3 LVAD and RVAD Segment by Application
1.3.1 Global LVAD and RVAD Market Value by Application: (2023-2029)
1.3.2 Bridge-to-transplant (BTT)
1.3.3 Destination Therapy (DT)
1.3.4 Others
1.4 Global LVAD and RVAD Market Size Estimates and Forecasts
1.4.1 Global LVAD and RVAD Revenue 2018-2029
1.4.2 Global LVAD and RVAD Sales 2018-2029
1.4.3 Global LVAD and RVAD Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 LVAD and RVAD Market Competition by Manufacturers
2.1 Global LVAD and RVAD Sales Market Share by Manufacturers (2018-2023)
2.2 Global LVAD and RVAD Revenue Market Share by Manufacturers (2018-2023)
2.3 Global LVAD and RVAD Average Price by Manufacturers (2018-2023)
2.4 Global LVAD and RVAD Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of LVAD and RVAD, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of LVAD and RVAD, Product Type & Application
2.7 LVAD and RVAD Market Competitive Situation and Trends
2.7.1 LVAD and RVAD Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest LVAD and RVAD Players Market Share by Revenue
2.7.3 Global LVAD and RVAD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 LVAD and RVAD Retrospective Market Scenario by Region
3.1 Global LVAD and RVAD Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global LVAD and RVAD Global LVAD and RVAD Sales by Region: 2018-2029
3.2.1 Global LVAD and RVAD Sales by Region: 2018-2023
3.2.2 Global LVAD and RVAD Sales by Region: 2024-2029
3.3 Global LVAD and RVAD Global LVAD and RVAD Revenue by Region: 2018-2029
3.3.1 Global LVAD and RVAD Revenue by Region: 2018-2023
3.3.2 Global LVAD and RVAD Revenue by Region: 2024-2029
3.4 North America LVAD and RVAD Market Facts & Figures by Country
3.4.1 North America LVAD and RVAD Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America LVAD and RVAD Sales by Country (2018-2029)
3.4.3 North America LVAD and RVAD Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe LVAD and RVAD Market Facts & Figures by Country
3.5.1 Europe LVAD and RVAD Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe LVAD and RVAD Sales by Country (2018-2029)
3.5.3 Europe LVAD and RVAD Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific LVAD and RVAD Market Facts & Figures by Country
3.6.1 Asia Pacific LVAD and RVAD Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific LVAD and RVAD Sales by Country (2018-2029)
3.6.3 Asia Pacific LVAD and RVAD Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America LVAD and RVAD Market Facts & Figures by Country
3.7.1 Latin America LVAD and RVAD Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America LVAD and RVAD Sales by Country (2018-2029)
3.7.3 Latin America LVAD and RVAD Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa LVAD and RVAD Market Facts & Figures by Country
3.8.1 Middle East and Africa LVAD and RVAD Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa LVAD and RVAD Sales by Country (2018-2029)
3.8.3 Middle East and Africa LVAD and RVAD Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global LVAD and RVAD Sales by Type (2018-2029)
4.1.1 Global LVAD and RVAD Sales by Type (2018-2023)
4.1.2 Global LVAD and RVAD Sales by Type (2024-2029)
4.1.3 Global LVAD and RVAD Sales Market Share by Type (2018-2029)
4.2 Global LVAD and RVAD Revenue by Type (2018-2029)
4.2.1 Global LVAD and RVAD Revenue by Type (2018-2023)
4.2.2 Global LVAD and RVAD Revenue by Type (2024-2029)
4.2.3 Global LVAD and RVAD Revenue Market Share by Type (2018-2029)
4.3 Global LVAD and RVAD Price by Type (2018-2029)
5 Segment by Application
5.1 Global LVAD and RVAD Sales by Application (2018-2029)
5.1.1 Global LVAD and RVAD Sales by Application (2018-2023)
5.1.2 Global LVAD and RVAD Sales by Application (2024-2029)
5.1.3 Global LVAD and RVAD Sales Market Share by Application (2018-2029)
5.2 Global LVAD and RVAD Revenue by Application (2018-2029)
5.2.1 Global LVAD and RVAD Revenue by Application (2018-2023)
5.2.2 Global LVAD and RVAD Revenue by Application (2024-2029)
5.2.3 Global LVAD and RVAD Revenue Market Share by Application (2018-2029)
5.3 Global LVAD and RVAD Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbioMed
6.1.1 AbioMed Corporation Information
6.1.2 AbioMed Description and Business Overview
6.1.3 AbioMed LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbioMed LVAD and RVAD Product Portfolio
6.1.5 AbioMed Recent Developments/Updates
6.2 Abbott (Thoratec)
6.2.1 Abbott (Thoratec) Corporation Information
6.2.2 Abbott (Thoratec) Description and Business Overview
6.2.3 Abbott (Thoratec) LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott (Thoratec) LVAD and RVAD Product Portfolio
6.2.5 Abbott (Thoratec) Recent Developments/Updates
6.3 Medtronic (HeartWare)
6.3.1 Medtronic (HeartWare) Corporation Information
6.3.2 Medtronic (HeartWare) Description and Business Overview
6.3.3 Medtronic (HeartWare) LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic (HeartWare) LVAD and RVAD Product Portfolio
6.3.5 Medtronic (HeartWare) Recent Developments/Updates
6.4 Berlin Heart
6.4.1 Berlin Heart Corporation Information
6.4.2 Berlin Heart Description and Business Overview
6.4.3 Berlin Heart LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Berlin Heart LVAD and RVAD Product Portfolio
6.4.5 Berlin Heart Recent Developments/Updates
6.5 Jarvik Heart
6.5.1 Jarvik Heart Corporation Information
6.5.2 Jarvik Heart Description and Business Overview
6.5.3 Jarvik Heart LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Jarvik Heart LVAD and RVAD Product Portfolio
6.5.5 Jarvik Heart Recent Developments/Updates
6.6 Sun Medical Technology Research
6.6.1 Sun Medical Technology Research Corporation Information
6.6.2 Sun Medical Technology Research Description and Business Overview
6.6.3 Sun Medical Technology Research LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sun Medical Technology Research LVAD and RVAD Product Portfolio
6.6.5 Sun Medical Technology Research Recent Developments/Updates
6.7 ReliantHeart
6.6.1 ReliantHeart Corporation Information
6.6.2 ReliantHeart Description and Business Overview
6.6.3 ReliantHeart LVAD and RVAD Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ReliantHeart LVAD and RVAD Product Portfolio
6.7.5 ReliantHeart Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 LVAD and RVAD Industry Chain Analysis
7.2 LVAD and RVAD Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 LVAD and RVAD Production Mode & Process
7.4 LVAD and RVAD Sales and Marketing
7.4.1 LVAD and RVAD Sales Channels
7.4.2 LVAD and RVAD Distributors
7.5 LVAD and RVAD Customers
8 LVAD and RVAD Market Dynamics
8.1 LVAD and RVAD Industry Trends
8.2 LVAD and RVAD Market Drivers
8.3 LVAD and RVAD Market Challenges
8.4 LVAD and RVAD Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
